Implanet Announces Its 2016 First-Half Results: Buoyant Growth In Revenue And Substantial Gross Margin Improvement
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (Paris:IMPL) (OTCQX:IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announces its financial results for the 1st half of the year to June 30, 2016, as approved by the Board at its meeting of September 20, 2016.